Page results
-
Introduction of Bordetella pertussis PCR testing at Halo laboratory (Health Services Laboratories)
-
Cancer surgery at UCLH on Operation Ouch
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
Bladder cancer is where a growth of abnormal tissue, known as a tumour, develops in the bladder lining. In some cases, the tumour spreads into the surrounding areas.
-
The North Central London Integrated Care System (NCL ICS) has new services and staff training to support patients with inherited red cell disorders, including Sickle Cell and Thalassaemia, living in Barnet, Camden, Enfield, Haringey and Islington.
-
A national study with initial results shows steroid dexamethasone may substantially reduce mortality in severely ill Covid-19 patients.
-
Participants reacted quicker and made fewer errors during menstruation, despite believing their performance would be worse, according to new research from UCL and the Institute of Sport, Exercise & Health (ISEH).
-
Ensuring that UCLH staff understand the urgency of the climate crisis and support our net zero programme is crucial if we want to be successful in reaching our goal of net zero carbon emissions by 2031. Our patients must be kept informed of changes and we must work closely with other NHS organisations, including NHS England, if we are to deliver a successful programme. This page documents our progress to date.
-
An immunotherapy drug given before surgery instead of chemotherapy meant that significantly more patients with a certain genetic profile were cancer free after surgery, according to clinical trial results presented by researchers at UCL and UCLH.
-
As an organisation, UCLH needs to minimise the environmental impact of our buildings and the energy they use and maximise our use of any technology available to support these changes. This page outlines our progress to date.
File results
-
FOI/2023/0226 - Treatment with Nivolumab
-
FOI/2023/0225 - Usage of Dabrafenib + Trametinib in cancer treatment
-
FOI/2023/0224 - Patients prescribed medical equipment for use in the home
-
FOI/2023/0222 - Contact details for senior screening and immunisations staff
-
FOI/2023/0220 - Internally produced patient information leaflets
-
FOI/2023/0218 - System for discharge letters, diagnostic reporting, digital dictation & bed management
-
FOI/2023/0217 - Integration platform(s) at the Trust
-
FOI/2023/0215 - British sign language procurement and communications
-
FOI/2023/0214 - Patients waiting over 78 weeks for elective care
-
FOI/2023/0110 - General anaesthesia paediatric dental waiting times